Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL7502003 | 0.81 | TSHR (0.38) | ESR2 | |
| SCHEMBL8728482 | 0.80 | — | — | |
| SCHEMBL180095 | 0.78 | — | — | |
| SCHEMBL16730136 | 0.78 | — | — | |
| SCHEMBL16750985 | 0.78 | — | — | |
| SCHEMBL112236 | 0.76 | ESR2 (0.40) | ESR2 | |
| SCHEMBL16378093 | 0.76 | TSHR (0.35) | — | |
| SCHEMBL9815694 | 0.74 | TSHR (0.43) | ESR2 | |
| Cyclohexanol SCHEMBL596771 | 0.74 | TSHR (0.50) | ESR2 | |
| Cyclohexanol SCHEMBL595842 | 0.74 | TSHR (0.50) | ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1609362-B1 | Non-systemic control of parasites | BAYER IP GMBH (DE) | 2015-03-18 | — | — | EP | disclosed |
| US-8728507-B2 | Non-systemic control of parasites | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-20 | — | — | US | disclosed |
| US-7517535-B2 | Non-systemic control of parasites | BAYER ANIMAL HEALTH GMBH (DE) | 2009-04-14 | — | — | US | disclosed |
| US-20080108670-A1 | NON-SYSTEMIC CONTROL OF PARASITES | BAYER HEALTHCARE AG (DE) | 2008-05-08 | — | — | US | disclosed |
| US-20080108671-A1 | NON-SYSTEMIC CONTROL OF PARASITES | BAYER HEALTHCARE AG (DE) | 2008-05-08 | — | — | US | disclosed |
| US-20060276517-A1 | Non-systemic control of parasites | BAYER HEALTHCARE AG (DE) | 2006-12-07 | — | — | US | disclosed |
| EP-1609362-A2 | Non-systemic control of parasites | Bayer HealthCare AG (DE) | 2005-12-28 | — | — | EP | disclosed |
| EP-0682869-B1 | Non-systemic control of parasites | BAYER HEALTHCARE AG (DE) | 2005-12-21 | — | — | EP | disclosed |
| US-20050222217-A1 | Non-systemic control of parasites | BAYER HEALTHCARE AG (DE) | 2005-10-06 | — | — | US | disclosed |
| US-6896891-B2 | Non-systemic control of parasites | BAYER AKTIENGESELLSCHAFT (DE) | 2005-05-24 | — | — | US | disclosed |
| US-20010027201-A1 | Non-systemic control of parasites | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2001-10-04 | — | — | US | disclosed |
| US-20010021716-A1 | Non-systemic control of parasites | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2001-09-13 | — | — | US | disclosed |
| US-6232328-B1 | CONTACTING FLEAS AND LIC ON A HUMAN OR ANIMALS WITH AN IMIDAZOLINIUM COMPOUND TO KILL FLIES AND INSECTS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-15 | — | — | US | disclosed |
| CN-1203611-A | Process for production of rigid polyurethane foams in presence of hydrocarbon blowing agents | ICI PLC (GB) | 1998-12-30 | — | — | CN | disclosed |
| EP-0682869-A1 | Non-systemic control of parasites | BAYER AG (DE) | 1995-11-22 | — | — | EP | disclosed |
| EP-0569791-A2 | Shaped bodies for the control of ektoparasites on animals | BAYER AG (DE) | 1993-11-18 | — | — | EP | disclosed |
| EP-0528303-A1 | Shaped bodies for the control of undesired organisms | BAYER AG (DE) | 1993-02-24 | — | — | EP | disclosed |
| EP-0050782-A1 | Pet collars containing ectoparasiticides | BAYER AG (DE) | 1982-05-05 | — | — | EP | disclosed |
| EP-0050784-A1 | Polyurethanes containing ectoparasecticides | BAYER AG (DE) | 1982-05-05 | — | — | EP | disclosed |
| EP-0000761-B1 | PROCESS FOR THE PREPARATION OF POLYURETHANE FOAMS | BAYER AG (DE) | 1981-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276517-A1 | Non-systemic control of parasites | CHRNG, CHRNA1, CHRM3 | AKR1B10 3990/4885ESR2 1437/4885 |
| US-20080108671-A1 | NON-SYSTEMIC CONTROL OF PARASITES | CHRNG, CHRNA1, CHRM3 | AKR1B10 3990/4885ESR2 1437/4885 |
| US-20010021716-A1 | Non-systemic control of parasites | CHRNG, CHRNA1, CHRM3 | AKR1B10 3990/4885ESR2 1437/4885 |
| US-20050222217-A1 | Non-systemic control of parasites | CHRNG, CHRNA1, CHRM3 | AKR1B10 3990/4885ESR2 1437/4885 |
| US-20080108670-A1 | NON-SYSTEMIC CONTROL OF PARASITES | CHRNG, CHRNA1, CHRM3 | AKR1B10 3990/4885ESR2 1437/4885 |
| US-20010027201-A1 | Non-systemic control of parasites | CHRNG, CHRNA1, CHRM3 | AKR1B10 3990/4885ESR2 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.